Delcath Systems vs Iradimed
Delcath Systems and Iradimed are similar in size: $85.2m and $83.8m of revenue in their latest fiscal years. Delcath Systems grew faster (129.1% against 14.4%). Iradimed kept more of each dollar of sales as profit: a net margin of 26.8% against 3.2%. Delcath Systems carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Delcath SystemsDCTH, 2025 | IradimedIRMD, 2025 |
|---|---|---|
| Revenue | $85.2m | $83.8m |
| Revenue growth | 129.1% | 14.4% |
| Net income | $2.7m | $22.5m |
| Operating margin | 0.8% | 31.2% |
| Net margin | 3.2% | 26.8% |
| Return on equity | 3.0% | 24.8% |
| Free cash flow | $21.0m | $17.2m |
| Cash | $43.5m | $51.2m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | 1.6% |
| Share buybacks | $6.0m | — |
| Employees | 156 | — |
| Market value | $500m | $1.03bn |
| Price vs our value range | — | Above our value range |
| Moat score | 25 (Weak) | 81 (Strong) |
| Insider trades, 12 months | 4 buys, 0 sales | 0 buys, 116 sales |